Asked by: Rachael Maskell (Labour (Co-op) - York Central)
Question to the Department of Health and Social Care:
To ask the Secretary of State for Health and Social Care, what guidance she issues tor GPs on working with Pharmacy First to reduce their workloads.
Answered by Andrea Leadsom - Parliamentary Under-Secretary (Department of Health and Social Care)
Pharmacy First was launched on 31 January 2024, and as the service embeds, we will monitor and evaluate the service and keep the conditions covered by Pharmacy First under review, but it is too early to consider expanding the clinical pathways.
In the Delivery plan for recovering access to primary care, we estimated that Pharmacy First, together with the expanded blood pressure check and contraception service, once fully scaled, could remove up to 10 million general practice (GP) appointments. We are monitoring the number of Pharmacy First consultations in community pharmacy but it is not possible to monitor the number of GP appointments Pharmacy First frees up. However, we know that Pharmacy First will enable GPs to see patients with more complex needs quicker.
Since 2019, GPs and their teams have already been referring patients to community pharmacies for minor illnesses and Pharmacy First builds on this. NHS England has engaged with GPs during the development and launch of Pharmacy First and Community Pharmacy England has launched a dedicated website for GPs supporting them with Pharmacy First referrals.
Pharmacies are not paid an establishment grant. Contractors who have signed up to deliver Pharmacy First received a £2,000 set-up fee, they receive £15 per consultation and £1,000 for each month they reach an agreed minimum number of consultations. Funding for community pharmacies, including the funding for Pharmacy First, is expected to pay for all their costs in providing the service. There are no delays to Pharmacy First payments. All payments are made in line with the usual schedule of payments.
The statutory National Minimum Wage and National Living Wage is based on advice of the Low Pay Commission, which takes into account the impact on business and the wider economy, as well as the living standards of workers.
Asked by: Rachael Maskell (Labour (Co-op) - York Central)
Question to the Department of Health and Social Care:
To ask the Secretary of State for Health and Social Care, if she will take steps to monitor the number of GP appointments that are freed up as a result of Pharmacy First.
Answered by Andrea Leadsom - Parliamentary Under-Secretary (Department of Health and Social Care)
Pharmacy First was launched on 31 January 2024, and as the service embeds, we will monitor and evaluate the service and keep the conditions covered by Pharmacy First under review, but it is too early to consider expanding the clinical pathways.
In the Delivery plan for recovering access to primary care, we estimated that Pharmacy First, together with the expanded blood pressure check and contraception service, once fully scaled, could remove up to 10 million general practice (GP) appointments. We are monitoring the number of Pharmacy First consultations in community pharmacy but it is not possible to monitor the number of GP appointments Pharmacy First frees up. However, we know that Pharmacy First will enable GPs to see patients with more complex needs quicker.
Since 2019, GPs and their teams have already been referring patients to community pharmacies for minor illnesses and Pharmacy First builds on this. NHS England has engaged with GPs during the development and launch of Pharmacy First and Community Pharmacy England has launched a dedicated website for GPs supporting them with Pharmacy First referrals.
Pharmacies are not paid an establishment grant. Contractors who have signed up to deliver Pharmacy First received a £2,000 set-up fee, they receive £15 per consultation and £1,000 for each month they reach an agreed minimum number of consultations. Funding for community pharmacies, including the funding for Pharmacy First, is expected to pay for all their costs in providing the service. There are no delays to Pharmacy First payments. All payments are made in line with the usual schedule of payments.
The statutory National Minimum Wage and National Living Wage is based on advice of the Low Pay Commission, which takes into account the impact on business and the wider economy, as well as the living standards of workers.
Asked by: Rachael Maskell (Labour (Co-op) - York Central)
Question to the Department of Health and Social Care:
To ask the Secretary of State for Health and Social Care, whether she plans to expand the number of clinical pathways under Pharmacy First services.
Answered by Andrea Leadsom - Parliamentary Under-Secretary (Department of Health and Social Care)
Pharmacy First was launched on 31 January 2024, and as the service embeds, we will monitor and evaluate the service and keep the conditions covered by Pharmacy First under review, but it is too early to consider expanding the clinical pathways.
In the Delivery plan for recovering access to primary care, we estimated that Pharmacy First, together with the expanded blood pressure check and contraception service, once fully scaled, could remove up to 10 million general practice (GP) appointments. We are monitoring the number of Pharmacy First consultations in community pharmacy but it is not possible to monitor the number of GP appointments Pharmacy First frees up. However, we know that Pharmacy First will enable GPs to see patients with more complex needs quicker.
Since 2019, GPs and their teams have already been referring patients to community pharmacies for minor illnesses and Pharmacy First builds on this. NHS England has engaged with GPs during the development and launch of Pharmacy First and Community Pharmacy England has launched a dedicated website for GPs supporting them with Pharmacy First referrals.
Pharmacies are not paid an establishment grant. Contractors who have signed up to deliver Pharmacy First received a £2,000 set-up fee, they receive £15 per consultation and £1,000 for each month they reach an agreed minimum number of consultations. Funding for community pharmacies, including the funding for Pharmacy First, is expected to pay for all their costs in providing the service. There are no delays to Pharmacy First payments. All payments are made in line with the usual schedule of payments.
The statutory National Minimum Wage and National Living Wage is based on advice of the Low Pay Commission, which takes into account the impact on business and the wider economy, as well as the living standards of workers.
Asked by: Rachael Maskell (Labour (Co-op) - York Central)
Question to the Department of Health and Social Care:
To ask the Secretary of State for Health and Social Care, if she will make an assessment of the adequacy of the establishment grant for pharmacies extending into Pharmacy First for (a) consulting and (b) waiting facilities.
Answered by Andrea Leadsom - Parliamentary Under-Secretary (Department of Health and Social Care)
Pharmacy First was launched on 31 January 2024, and as the service embeds, we will monitor and evaluate the service and keep the conditions covered by Pharmacy First under review, but it is too early to consider expanding the clinical pathways.
In the Delivery plan for recovering access to primary care, we estimated that Pharmacy First, together with the expanded blood pressure check and contraception service, once fully scaled, could remove up to 10 million general practice (GP) appointments. We are monitoring the number of Pharmacy First consultations in community pharmacy but it is not possible to monitor the number of GP appointments Pharmacy First frees up. However, we know that Pharmacy First will enable GPs to see patients with more complex needs quicker.
Since 2019, GPs and their teams have already been referring patients to community pharmacies for minor illnesses and Pharmacy First builds on this. NHS England has engaged with GPs during the development and launch of Pharmacy First and Community Pharmacy England has launched a dedicated website for GPs supporting them with Pharmacy First referrals.
Pharmacies are not paid an establishment grant. Contractors who have signed up to deliver Pharmacy First received a £2,000 set-up fee, they receive £15 per consultation and £1,000 for each month they reach an agreed minimum number of consultations. Funding for community pharmacies, including the funding for Pharmacy First, is expected to pay for all their costs in providing the service. There are no delays to Pharmacy First payments. All payments are made in line with the usual schedule of payments.
The statutory National Minimum Wage and National Living Wage is based on advice of the Low Pay Commission, which takes into account the impact on business and the wider economy, as well as the living standards of workers.
Asked by: Ruth Jones (Labour - Newport West)
Question to the Foreign, Commonwealth & Development Office:
To ask the Deputy Foreign Secretary, how many Ministerial visits have taken place to Southern African Development Community nations in each of the last ten years.
Answered by Andrew Mitchell - Minister of State (Foreign, Commonwealth and Development Office) (Minister for Development)
The UK recognises the important role the Southern African Development Community (SADC) has in relation to regional issues. I [Minister Mitchell] regularly discuss a range of issues, including peace and security and UK-SADC collaboration, with regional partners. In the past 12 months I have travelled to Tanzania, South Africa, Mozambique, Zambia, DRC with plans to visit a further two SADC countries in the next 3 months and have also met with the region at World Bank Spring Meetings, AfDB annual meetings and the UN General Assembly.
The information requested on the previous 10 years is not held centrally by the Department and complying with this request would incur a disproportionate cost to the Department.
Asked by: Alison McGovern (Labour - Wirral South)
Question to the Department of Health and Social Care:
To ask the Secretary of State for Health and Social Care, what discussions her Department has had with cancer treatment support groups on the use of direct funds to support patients and their families.
Answered by Andrew Stephenson - Minister of State (Department of Health and Social Care)
The Government is working jointly with NHS England on implementing the delivery plan for tackling the COVID-19 backlogs in elective care, and plans to spend more than £8 billion from 2022/23 to 2024/25 to help drive up and protect elective activity, including cancer treatment, which encompasses recovery spaces. Additionally, and as outlined in the 2024/25 NHS England Planning Guidance, NHS England are providing over £266 million in cancer service development funding to Cancer Alliances, to support delivery of the operational priorities for cancer.
The Department and NHS England meet regularly to discuss a wide range of issues regarding cancer. The Department's ministers and officials also frequently meet with key stakeholders within the cancer community, including discussions on support for patients and their families. As stated in the NHS Long Term Plan for Cancer, where appropriate, every person diagnosed with cancer will have access to personalised care, including needs assessment, a care plan and health and wellbeing information, and support. NHS England provides personalised cancer care and support plans, to support both patients and their families at all stages of their cancer journey. This is being delivered in line with the NHS Comprehensive Model for Personalised Care, empowering people to manage their care and the impact of their cancer, and maximise the potential of digital and community-based support. NHS England estimates that approximately 80% of cancer multidisciplinary teams are now offering Personalised Care and Support Planning, ensuring physical, practical, emotional, and social needs are identified and addressed at all stages of the cancer pathway. Additionally, Personalised Stratified Follow Up pathways, which adapt care to the needs of individual patients after cancer treatment, are being rolled out by cancer multi-disciplinary teams, and are required for at least eight cancer types by 2023/24.
General practice surgeries also conduct cancer care reviews at regular intervals after cancer diagnosis, to offer support with any needs patients may have. This includes providing access to other specialist-led services who work alongside patients’ medical teams, to support patients and their families, such as counsellors, rehabilitation specialists, or social prescribers, who can connect you to community groups or services for more support. This is part of NHS England’s drive to universal personalised care that will see at least 2.5 million people benefiting from personalised care by 2023/24.
NHS England and the integrated care boards are responsible for commissioning and ensuring the healthcare needs of local communities in England are met, including for cancer patients. NHS England provide access to a personal health budget, which is an amount of NHS money that is allocated to support the health and wellbeing needs of a patient if eligible. More information is available at the following link:
https://www.nhs.uk/nhs-services/help-with-health-costs/what-is-a-personal-health-budget/
Asked by: Alison McGovern (Labour - Wirral South)
Question to the Department of Health and Social Care:
To ask the Secretary of State for Health and Social Care, what funding has her Department allocated to provide recovery spaces for families of cancer treatment patients.
Answered by Andrew Stephenson - Minister of State (Department of Health and Social Care)
The Government is working jointly with NHS England on implementing the delivery plan for tackling the COVID-19 backlogs in elective care, and plans to spend more than £8 billion from 2022/23 to 2024/25 to help drive up and protect elective activity, including cancer treatment, which encompasses recovery spaces. Additionally, and as outlined in the 2024/25 NHS England Planning Guidance, NHS England are providing over £266 million in cancer service development funding to Cancer Alliances, to support delivery of the operational priorities for cancer.
The Department and NHS England meet regularly to discuss a wide range of issues regarding cancer. The Department's ministers and officials also frequently meet with key stakeholders within the cancer community, including discussions on support for patients and their families. As stated in the NHS Long Term Plan for Cancer, where appropriate, every person diagnosed with cancer will have access to personalised care, including needs assessment, a care plan and health and wellbeing information, and support. NHS England provides personalised cancer care and support plans, to support both patients and their families at all stages of their cancer journey. This is being delivered in line with the NHS Comprehensive Model for Personalised Care, empowering people to manage their care and the impact of their cancer, and maximise the potential of digital and community-based support. NHS England estimates that approximately 80% of cancer multidisciplinary teams are now offering Personalised Care and Support Planning, ensuring physical, practical, emotional, and social needs are identified and addressed at all stages of the cancer pathway. Additionally, Personalised Stratified Follow Up pathways, which adapt care to the needs of individual patients after cancer treatment, are being rolled out by cancer multi-disciplinary teams, and are required for at least eight cancer types by 2023/24.
General practice surgeries also conduct cancer care reviews at regular intervals after cancer diagnosis, to offer support with any needs patients may have. This includes providing access to other specialist-led services who work alongside patients’ medical teams, to support patients and their families, such as counsellors, rehabilitation specialists, or social prescribers, who can connect you to community groups or services for more support. This is part of NHS England’s drive to universal personalised care that will see at least 2.5 million people benefiting from personalised care by 2023/24.
NHS England and the integrated care boards are responsible for commissioning and ensuring the healthcare needs of local communities in England are met, including for cancer patients. NHS England provide access to a personal health budget, which is an amount of NHS money that is allocated to support the health and wellbeing needs of a patient if eligible. More information is available at the following link:
https://www.nhs.uk/nhs-services/help-with-health-costs/what-is-a-personal-health-budget/
Asked by: Baroness Finlay of Llandaff (Crossbench - Life peer)
Question to the Department of Health and Social Care:
To ask His Majesty's Government how they plan to formally engage with the wider health sector and industry partners on the next stages in the development of proposed changes to Part IX of the Drug Tariff, following the conclusion of the consultation on these proposals.
Answered by Lord Markham - Parliamentary Under-Secretary (Department of Health and Social Care)
The consultation response on the proposed amendments to Part IX and the final impact assessment is expected to be released in May 2024, and will outline the Government’s response.
The Department believes that it is currently difficult to identify which devices are broadly comparable, and whether more expensive devices provide added value. The proposed amendments that were consulted on intend to increase meaningful choice, not to decrease choice for clinicians and patients. Comparison between products can increase awareness of different brands amongst prescribers.
These proposals support the Life Sciences Vision, and are designed to increase innovation and alignment between partners in the health and care system. The enhanced assessment process will allow comparison between products based on their merits, increasing transparency and competition, and encouraging new products and small and medium sized businesses to enter the market. The proposed introduction of environmental attributes in social value scoring increases the vision to help the National Health Service meet Net Zero.
The Department is aware that there are some very good devices in use, relied upon by clinicians and patients. Part IX will remain a list of devices available to be prescribed in the community via the FP10 prescription route. Any amendments that are taken forward will happen gradually, with review points and engagement with stakeholders, including industry, patient representatives, clinicians, and NHS organisations. The Department will share a timeline of proposed changes taken forward, in due course.
Asked by: Lord Hunt of Kings Heath (Labour - Life peer)
Question to the Department of Health and Social Care:
To ask His Majesty's Government what plans they have to consult patients, clinicians and manufacturers on the categorisation of products available on Part IX of the Drug Tariff as proposed in the recent consultation paper; and what assessment they have made of the impact of the proposed changes to Drug Tariff Part IX on (1) patients with continence care needs, (2) continence care services, (3) the range of devices available to clinicians and patients, and (4) new product development and innovation in medical devices in the continence sector.
Answered by Lord Markham - Parliamentary Under-Secretary (Department of Health and Social Care)
The consultation response on the proposed amendments to Part IX is expected to be released in May 2024, which will outline the Government’s response. Any amendments that are taken forward will happen gradually, with review points, and engagement with stakeholders, including industry, patient representatives, clinicians, and National Health Service organisations. The Department will share a timeline of the proposed changes taken forward in due course.
The Department believes that it is currently difficult to identify which devices are broadly comparable, and whether more expensive devices provide added value. The proposed amendments that were consulted on intend to increase meaningful choice, not to decrease choice for clinicians and patients. Comparison between products can increase awareness of different brands amongst prescribers, which can also support small and medium sized businesses in entering the market.
The Department is aware that there are some very good devices in use, relied upon by clinicians and patients. Part IX will remain a list of devices available to be prescribed in the community via the FP10 prescription route.
Asked by: Janet Daby (Labour - Lewisham East)
Question to the Department of Health and Social Care:
To ask the Secretary of State for Health and Social Care, if she will make an estimate on the waiting times for (a) assessment for and (b) diagnosis of autism in (i) adults and (ii) children in Lewisham East constituency.
Answered by Maria Caulfield - Parliamentary Under Secretary of State (Department for Business and Trade) (Minister for Women)
The information requested is not held centrally, but may be held by individual providers or integrated care boards (ICBs). Some relevant information is available on autism assessment waiting times for the NHS South East London ICB. In December 2023, the NHS South East London ICB’s Autism Waiting Time Statistics show that there were a total of 1,425 patients with an open suspected autism referral. 100 of these patients were aged between 0 and 17 years old, and 1,325 of these patients were aged 18 years old and over.
The median waiting time of all patients in this ICB, with an open suspected autism referral, where their first care contact was in the quarter, was 545 days. For 0 to 17 year olds, the median number of days patients waited was 149 days, compared to 606 days for over 18 year olds.
Data on children and young people in this dataset is expected to be an underestimate, and caution should be used when interpreting these statistics, since they are experimental rather than official statistics. The majority of children assessed for autism in the United Kingdom are seen in child development services, which are out of the scope of this dataset. This means the published figures will underestimate the volume of referrals or diagnoses, and the associated impact on health services. NHS England continues to conduct exploratory analysis into the Community Services Dataset, with a view to including autism waiting times data from that dataset.